Explore
Trendline
Spruce Biosciences Initiates Public Offering of Common Stock and Pre-Funded Warrants
Spruce Biosciences Initiates Public Offering of Common Stock and Pre-Funded Warrants
Read More
Trendline
Spruce Biosciences Prices Public Offering to Raise $60 Million for Neurological Research
Spruce Biosciences Prices Public Offering to Raise $60 Million for Neurological Research
Read More
Trendline
Spruce Biosciences Prices Public Offering to Raise $60 Million
Spruce Biosciences Prices Public Offering to Raise $60 Million
Read More
Trendline
Spruce Biosciences Sets Pricing for Public Offering of Common Stock and Pre-Funded Warrants
Spruce Biosciences Sets Pricing for Public Offering of Common Stock and Pre-Funded Warrants
Read More
Trendline
Arrowhead Pharmaceuticals Anticipated to Gain from Upcoming Clinical Trial Data
Arrowhead Pharmaceuticals Anticipated to Gain from Upcoming Clinical Trial Data
Read More
Trendline
Driven Brands Faces Securities Fraud Allegations Over Financial Misstatements
Driven Brands Faces Securities Fraud Allegations Over Financial Misstatements
Read More
Trendline
Sidus Space Announces $58.5 Million Stock Offering to Boost Corporate Growth
Sidus Space Announces $58.5 Million Stock Offering to Boost Corporate Growth
Read More
Trendline
Auburn Football's New Era Under Coach Alex Golesh Focuses on Elite Quarterback Play
Auburn Football's New Era Under Coach Alex Golesh Focuses on Elite Quarterback Play
Read More
Trendline
Kentucky's Mo Dioubate Transfers to LSU, Strengthening Tigers' Roster
Kentucky's Mo Dioubate Transfers to LSU, Strengthening Tigers' Roster
Read More
Trendline
Bitmine Immersion Technologies Expands Ethereum Holdings to 4.976 Million Tokens, Total Assets Reach $12.9 Billion
Bitmine Immersion Technologies Expands Ethereum Holdings to 4.976 Million Tokens, Total Assets Reach $12.9 Billion
Read More
Trendline
LSU Women's Basketball Star Flau'jae Johnson Named Louisiana Player of the Year
LSU Women's Basketball Star Flau'jae Johnson Named Louisiana Player of the Year
Read More
Trendline
Eli Lilly Expands Genetic Medicine Portfolio with $7 Billion Acquisition of Kelonia Therapeutics
Eli Lilly Expands Genetic Medicine Portfolio with $7 Billion Acquisition of Kelonia Therapeutics
Read More